布鲁克（BRKR）股价在盘中出现大幅下跌，跌幅达5.38%。该公司股票在交易时段内表现低迷，引发市场关注。
造成股价下跌的主要原因是投资银行Stifel下调了布鲁克的目标价。Stifel将布鲁克的目标价从57.00美元下调至48.00美元，同时维持"持有"评级。这一消息对投资者情绪产生了明显影响，导致股价出现显著跌幅。
布鲁克公司主要为生命科学、制药和生物技术行业的客户生产科学仪器和诊断测试。公司最近的财报显示，实现营业收入8.01亿美元，净利润1740万美元，每股收益0.11美元。尽管公司业务稳定，但分析师的目标价下调显示市场对其未来增长前景的预期有所降低。在当前医疗器械行业整体上涨0.85%的背景下，布鲁克股价的大幅下跌更加引人注目。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.